Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

24.1.1

Definitions

Clinical HIV Guidelines, 5th Edition, 2022. Chapter 24, Pharmacovigilance.

Clinical description

Adverse Event (AE)

  • Any untoward medical occurrence in a patient. It does not necessarily have a causal relationship

with any medicine administered.

Adverse drug reaction (ADR)

  • An unintended noxious response to a medicinal product

Suspected adverse drug reaction

  • May present as a new sign, symptom, abnormal laboratory finding or specific disease
  • Suspected, but not confirmed to be caused by any medicine administered. Common causes of AEs

include advancement/complication of the underlying disease, manifestation of a new disease, or indeed the medicine administered.

  • Healthcare workers must report all suspected ADRs to the National Pharmacovigilance Centre at

Pharmacy and Medicines Regulatory Authority (PMRA)

Side effect (SE)

  • An unintended effect of a medicinal product occurring at doses normally used in humans, which is

related to its pharmacological properties.

  • All ADRs are AEs, but not all AEs are ADRs. All AEs and ADRs are harmful, but SEs can be either

harmful or beneficial.

Pharmacovigilance 117 Safety signal

  • An ADR which was previously either unknown or poorly documented in terms of its distribution,

severity, incidence or clinical presentation.

  • It is not possible, especially at bed side, to determine whether an individual case constitutes a

safety signal.

  • Pharmacovigilance aims to detect safety signals for period evaluation of the benefit-risk balance

of the medicine.

Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.